Indications
Treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults
Composition
- Active substance
- recombinant human nerve growth factor
- International name (INN)
- cenegermin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Oxervate
- Active substance
- recombinant human nerve growth factor
- ATC code
- S01
- Group
- Sensory organs
- Therapeutic area
- Keratitis
- Marketing authorisation holder
- Dompe' Farmaceutici S.p.A.
- Status
- Authorised